Tuesday, February 20, 2018
Matthew J. Rizzolo
Ropes & Gray LLP
Valeant Pharmaceuticals North America LLC and Valeant Pharmaceuticals International Inc.
Letter to Lisa R. Barton, Secretary, USITC; requesting that the Commission conduct an investigation under section 337 of the Tariff Act of 1930, as amended, regarding Certain Clidinium Bromide and Products Containing Same. The proposed respondents are Bi-Coastal Pharma International LLC, Shrewsbury, NJ; Bi-Coastal Pharmaceutical Corporation, Shrewsbury, NJ; ECI Pharmaceuticals LLC, Fort Lauderdale, FL; Virtus Pharmaceuticals LLC, Tampa, FL; and Virtus Pharmaceuticals OPCO II LLC, Nashville, TN.